GeSiM Partners with Yuri on Pioneering a 3D bioprinter for space:

Yuri, a leading space biotechnology company, has initiated a groundbreaking project: the development of the first European 3D bioprinter for space. Specializing in the use of the microgravity environment of space to develop and manufacture superior biotech products, Yuri has consistently pushed the boundaries of what is possible in biotechnology. They develop modular bioreactors and incubators for cell cultures, protein crystals, and plants, which they launch to the International Space Station (ISS) and other spacecraft such as the Sierra Nevada Dream Chaser and SpaceX Dragon. They also sell and rent devices to simulate microgravity on Earth, expanding the scope of their innovative solutions.

The recent launch of Yuri LUX’s project marks a new era for bioprinting in the medical field. A commercial bioprinter that can be utilized in lower earth orbit significantly expands research possibilities, allowing the microgravity printing environment to reach a higher number of scientists and institutes. Under such conditions, research results have significantly higher quality, after all some effects such as accelerated organic material aging, and cosmic radiation interaction are critical for the innovation-driven pharmaceutical, cosmetics and food sectors.

In this ambitious endeavor, GeSiM is proud to serve as a subcontractor and cooperation partner. We bring years of experience and profound expertise in 3D bioprinting, making us the ideal partner for this mission.  GeSiM has been engaged to deliver an innovative new iteration of our existing 3D printing hardware, specifically adapted for the space environment, aiming to improve processes and to overcome the challenges of energy and space restrictions.

The development is carried out both at the Luxembourg site and the GeSiM facility by a team of highly qualified engineers. The project Is funded by the Luxembourg Space Agency (LSA) through a contract with the European Space Agency (ESA) under the Luxembourg National Space Programme LuxIMPULSE.

With Yuri’s soon-to-open commercial market for their new ScienceTaxi BioForge, this project represents a significant leap forward in space biotechnology, promising to drive innovation and commercial opportunities in this exciting field.